Date Action Amount Person Type
Nov 02, 2022 Sell 2 135 Gross Paul Edward Common Stock
Nov 02, 2022 Sell 2 595 Gross Paul Edward Common Stock
Nov 02, 2022 Sell 2 006 Ivers-read Gillian C Common Stock
Nov 02, 2022 Sell 1 675 Ivers-read Gillian C Common Stock
Nov 02, 2022 Sell 915 Harding Thomas C. Common Stock
Nov 02, 2022 Sell 788 Harding Thomas C. Common Stock
Nov 02, 2022 Sell 63 Harding Thomas C. Common Stock
Nov 02, 2022 Sell 2 066 Muehl Daniel W Common Stock
Nov 02, 2022 Sell 2 513 Muehl Daniel W Common Stock
Nov 02, 2022 Sell 2 353 Rolfe Lindsey Common Stock
Nov 02, 2022 Sell 1 908 Rolfe Lindsey Common Stock
Nov 01, 2022 Buy 4 625 Gross Paul Edward Common Stock
Nov 01, 2022 Buy 5 623 Gross Paul Edward Common Stock
Nov 01, 2022 Sell 4 625 Gross Paul Edward Restricted Stock Units
Nov 01, 2022 Sell 5 623 Gross Paul Edward Restricted Stock Units
Nov 01, 2022 Buy 4 625 Ivers-read Gillian C Common Stock
Nov 01, 2022 Buy 3 749 Ivers-read Gillian C Common Stock
Nov 01, 2022 Sell 4 625 Ivers-read Gillian C Restricted Stock Units
Nov 01, 2022 Sell 3 749 Ivers-read Gillian C Restricted Stock Units
Nov 01, 2022 Buy 1 812 Harding Thomas C. Common Stock
Nov 01, 2022 Buy 1 562 Harding Thomas C. Common Stock
Nov 01, 2022 Sell 1 812 Harding Thomas C. Restricted Stock Units
Nov 01, 2022 Buy 181 Harding Thomas C. Common Stock
Nov 01, 2022 Sell 1 562 Harding Thomas C. Restricted Stock Units
Nov 01, 2022 Sell 181 Harding Thomas C. Restricted Stock Units
Nov 01, 2022 Buy 4 625 Muehl Daniel W Common Stock
Nov 01, 2022 Buy 5 623 Muehl Daniel W Common Stock
Nov 01, 2022 Sell 4 625 Muehl Daniel W Restricted Stock Units
Nov 01, 2022 Sell 5 623 Muehl Daniel W Restricted Stock Units
Nov 01, 2022 Buy 4 625 Rolfe Lindsey Common Stock
Nov 01, 2022 Buy 3 749 Rolfe Lindsey Common Stock
Nov 01, 2022 Sell 4 625 Rolfe Lindsey Restricted Stock Units
Nov 01, 2022 Sell 3 749 Rolfe Lindsey Restricted Stock Units
Oct 03, 2022 Sell 6 Harding Thomas C. Common Stock
Oct 01, 2022 Buy 15 Harding Thomas C. Common Stock
Oct 01, 2022 Sell 15 Harding Thomas C. Restricted Stock Units
Sep 02, 2022 Sell 1 444 Harding Thomas C. Common Stock
Sep 01, 2022 Buy 5 063 Rolfe Lindsey Common Stock
Sep 01, 2022 Sell 2 545 Rolfe Lindsey Common Stock
Sep 01, 2022 Buy 5 063 Rolfe Lindsey Restricted Stock Units
Sep 01, 2022 Sell 2 308 Gross Paul Edward Common Stock
Sep 01, 2022 Buy 5 063 Gross Paul Edward Restricted Stock Units
Sep 01, 2022 Buy 2 896 Harding Thomas C. Restricted Stock Units
Sep 01, 2022 Buy 2 896 Harding Thomas C. Common Stock
Sep 01, 2022 Buy 508 Harding Thomas C. Common Stock
Sep 01, 2022 Sell 172 Harding Thomas C. Common Stock
Sep 01, 2022 Buy 508 Harding Thomas C. Restricted Stock Units
Sep 01, 2022 Sell 2 234 Ivers-read Gillian C Common Stock
Sep 01, 2022 Buy 5 063 Ivers-read Gillian C Restricted Stock Units
Sep 01, 2022 Buy 5 063 Muehl Daniel W Common Stock
Sep 01, 2022 Sell 2 234 Muehl Daniel W Common Stock
Sep 01, 2022 Buy 5 063 Muehl Daniel W Restricted Stock Units
Aug 02, 2022 Sell 2 554 Muehl Daniel W Common Stock
Aug 02, 2022 Sell 2 391 Rolfe Lindsey Common Stock
Aug 02, 2022 Sell 930 Harding Thomas C. Common Stock
Aug 02, 2022 Sell 802 Harding Thomas C. Common Stock
Aug 01, 2022 Buy 4 625 Muehl Daniel W Common Stock
Aug 01, 2022 Buy 5 624 Muehl Daniel W Common Stock
Aug 01, 2022 Sell 2 100 Muehl Daniel W Common Stock
Aug 01, 2022 Sell 4 625 Muehl Daniel W Restricted Stock Units
Aug 01, 2022 Sell 5 624 Muehl Daniel W Restricted Stock Units
Aug 01, 2022 Buy 4 625 Rolfe Lindsey Common Stock
Aug 01, 2022 Buy 3 749 Rolfe Lindsey Common Stock
Aug 01, 2022 Sell 1 939 Rolfe Lindsey Common Stock
Aug 01, 2022 Sell 4 625 Rolfe Lindsey Restricted Stock Units
Aug 01, 2022 Sell 3 749 Rolfe Lindsey Restricted Stock Units
Aug 01, 2022 Buy 4 625 Ivers-read Gillian C Common Stock
Aug 01, 2022 Sell 1 702 Ivers-read Gillian C Common Stock
Aug 01, 2022 Sell 2 169 Gross Paul Edward Common Stock
Aug 01, 2022 Sell 5 624 Gross Paul Edward Restricted Stock Units
Aug 01, 2022 Buy 1 813 Harding Thomas C. Common Stock
Aug 01, 2022 Buy 1 563 Harding Thomas C. Common Stock
Aug 01, 2022 Sell 1 813 Harding Thomas C. Restricted Stock Units
Aug 01, 2022 Buy 181 Harding Thomas C. Common Stock
Aug 01, 2022 Sell 77 Harding Thomas C. Common Stock
Aug 01, 2022 Sell 1 563 Harding Thomas C. Restricted Stock Units
Aug 01, 2022 Sell 181 Harding Thomas C. Restricted Stock Units
Jul 01, 2022 Buy 16 Harding Thomas C. Common Stock
Jul 01, 2022 Sell 7 Harding Thomas C. Common Stock
Jul 01, 2022 Sell 16 Harding Thomas C. Restricted Stock Units
Jun 02, 2022 Sell 218 Harding Thomas C. Common Stock
Jun 01, 2022 Buy 2 896 Harding Thomas C. Restricted Stock Units
Jun 01, 2022 Buy 2 896 Harding Thomas C. Common Stock
Jun 01, 2022 Sell 1 504 Harding Thomas C. Common Stock
Jun 01, 2022 Buy 507 Harding Thomas C. Restricted Stock Units
Jun 01, 2022 Buy 507 Harding Thomas C. Common Stock
Jun 01, 2022 Buy 5 062 Muehl Daniel W Common Stock
Jun 01, 2022 Sell 2 327 Muehl Daniel W Common Stock
Jun 01, 2022 Buy 5 062 Muehl Daniel W Restricted Stock Units
Jun 01, 2022 Buy 5 062 Rolfe Lindsey Common Stock
Jun 01, 2022 Sell 2 650 Rolfe Lindsey Common Stock
Jun 01, 2022 Buy 5 062 Rolfe Lindsey Restricted Stock Units
Jun 01, 2022 Sell 2 403 Gross Paul Edward Common Stock
Jun 01, 2022 Buy 5 062 Gross Paul Edward Restricted Stock Units
Jun 01, 2022 Sell 2 327 Ivers-read Gillian C Common Stock
Jun 01, 2022 Buy 5 062 Ivers-read Gillian C Restricted Stock Units
May 02, 2022 Sell 2 062 Muehl Daniel W Common Stock
May 01, 2022 Sell 1 671 Ivers-read Gillian C Common Stock
May 01, 2022 Sell 4 625 Ivers-read Gillian C Restricted Stock Units
May 01, 2022 Buy 4 625 Muehl Daniel W Common Stock
INSIDER POWER
-0.167
Last 100 transactions
Buy: 146 624 | Sell: 133 052 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be negative at a ratio of -0.167.

In total, the insiders bought 146 624 and sold 133 052 CLVS shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Clovis Oncology

Clovis Oncology Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, as well as for metastatic castration-resistant prostate cancer. In Europe, the... CLVS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT